These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23609451)

  • 1. Increased chemosensitivity via targeting testicular nuclear receptor 4 (TR4)-Oct4-interleukin 1 receptor antagonist (IL1Ra) axis in prostate cancer CD133+ stem/progenitor cells to battle prostate cancer.
    Yang DR; Ding XF; Luo J; Shan YX; Wang R; Lin SJ; Li G; Huang CK; Zhu J; Chen Y; Lee SO; Chang C
    J Biol Chem; 2013 Jun; 288(23):16476-16483. PubMed ID: 23609451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression.
    Zhu J; Yang DR; Sun Y; Qiu X; Chang HC; Li G; Shan Y; Chang C
    Mol Cancer Ther; 2015 Jun; 14(6):1445-53. PubMed ID: 25833838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of miR‑145 and testicular nuclear receptor 4 inhibition to reduce chemoresistance to docetaxel in prostate cancer.
    Zhu J; Qin P; Cao C; Dai G; Xu L; Yang D
    Oncol Rep; 2021 Mar; 45(3):963-974. PubMed ID: 33650661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting TR4 nuclear receptor suppresses prostate cancer invasion via reduction of infiltrating macrophages with alteration of the TIMP-1/MMP2/MMP9 signals.
    Ding X; Yang DR; Xia L; Chen B; Yu S; Niu Y; Wang M; Li G; Chang C
    Mol Cancer; 2015 Jan; 14(1):16. PubMed ID: 25623427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting TR4 nuclear receptor with antagonist bexarotene increases docetaxel sensitivity to better suppress the metastatic castration-resistant prostate cancer progression.
    Hu L; Sun Y; Luo J; He X; Ye M; Li G; Zhang Y; Bai J; Zhang D; Chang C
    Oncogene; 2020 Feb; 39(9):1891-1903. PubMed ID: 31748715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR-373-3p expression to alter TGFβR2/p-Smad3 signals.
    Qiu X; Zhu J; Sun Y; Fan K; Yang DR; Li G; Yang G; Chang C
    Oncotarget; 2015 Jun; 6(17):15397-409. PubMed ID: 25980442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TR4 nuclear receptor promotes prostate cancer metastasis via upregulation of CCL2/CCR2 signaling.
    Ding X; Yang DR; Lee SO; Chen YL; Xia L; Lin SJ; Yu S; Niu YJ; Li G; Chang C
    Int J Cancer; 2015 Feb; 136(4):955-64. PubMed ID: 24975468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity.
    Chen D; Chou FJ; Chen Y; Tian H; Wang Y; You B; Niu Y; Huang CP; Yeh S; Xing N; Chang C
    Cancer Lett; 2020 Dec; 495():100-111. PubMed ID: 32768524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Differential Effects of Anti-Diabetic Thiazolidinedione on Prostate Cancer Progression Are Linked to the TR4 Nuclear Receptor Expression Status.
    Lin SJ; Lin CY; Yang DR; Izumi K; Yan E; Niu X; Chang HC; Miyamoto H; Wang N; Li G; Chang C
    Neoplasia; 2015 Apr; 17(4):339-47. PubMed ID: 25925376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of testicular nuclear receptor 4 in chemo-resistance of docetaxel in castration-resistant prostate cancer.
    Chen B; Yu S; Ding X; Jing C; Xia L; Wang M; Matro E; Rehman F; Niu Y; Li G; Chang C
    Cancer Gene Ther; 2014 Oct; 21(10):411-5. PubMed ID: 25104727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.
    Wang M; Sun Y; Xu J; Lu J; Wang K; Yang DR; Yang G; Li G; Chang C
    Int J Cancer; 2018 Jul; 143(1):100-112. PubMed ID: 29396852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
    Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C
    J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TR4 nuclear receptor enhances the cisplatin chemo-sensitivity via altering the ATF3 expression to better suppress HCC cell growth.
    Shen J; Lin H; Li G; Jin RA; Shi L; Chen M; Chang C; Cai X
    Oncotarget; 2016 May; 7(22):32088-99. PubMed ID: 27050071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enrichment of prostate cancer stem-like cells from human prostate cancer cell lines by culture in serum-free medium and chemoradiotherapy.
    Wang L; Huang X; Zheng X; Wang X; Li S; Zhang L; Yang Z; Xia Z
    Int J Biol Sci; 2013; 9(5):472-9. PubMed ID: 23781140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the TR4 nuclear receptor-mediated lncTASR/AXL signaling with tretinoin increases the sunitinib sensitivity to better suppress the RCC progression.
    Shi H; Sun Y; He M; Yang X; Hamada M; Fukunaga T; Zhang X; Chang C
    Oncogene; 2020 Jan; 39(3):530-545. PubMed ID: 31501521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TR
    Jin R; Lin H; Li G; Xu J; Shi L; Chang C; Cai X
    Cell Death Dis; 2018 Feb; 9(3):283. PubMed ID: 29449527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression analysis of putative stem cell markers in human benign and malignant prostate.
    Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
    Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human α(2)β(1)(HI) CD133(+VE) epithelial prostate stem cells express low levels of active androgen receptor.
    Williamson SC; Hepburn AC; Wilson L; Coffey K; Ryan-Munden CA; Pal D; Leung HY; Robson CN; Heer R
    PLoS One; 2012; 7(11):e48944. PubMed ID: 23145034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
    Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
    Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for orphan nuclear receptor TR4 in the etiology of Cushing disease.
    Du L; Bergsneider M; Mirsadraei L; Young SH; Jonker JW; Downes M; Yong WH; Evans RM; Heaney AP
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8555-60. PubMed ID: 23653479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.